A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Crohn Disease
In brief
This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.
Key facts
- Study ID
- NCT03464097
- Run by
- Celgene
- People needed
- 550
- Starts
- 2018-06-27
- Expected to finish
- 2024-10-03
- Last updated by the study team
- 2025-10-09
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Fulfilled the inclusion criteria at time of entry into the induction study and completed the week 12 efficacy assessments of the induction study
- In clinical response and/or clinical remission and/or an average daily stool frequency score ≤ 3 and an average abdominal pain score ≤ 1 with abdominal pain and stool frequency no worse than baseline at Week 12 of the Induction Study
You may not qualify if…
- Partial or total colectomy, small bowel resection, or an ostomy since day 1 of the induction studies or has developed a symptomatic fistula
- Had a rectal steroid therapy, rectal 5-aminosalicylates, parenteral corticosteroids, immunomodulatory agents, investigational agents or apheresis
- Other protocol-defined inclusion/exclusion criteria apply
Where it is running
- Local Institution - 202 — Scottsdale, Arizona, United States
- Local Institution - 026 — North Little Rock, Arkansas, United States
- Local Institution - 284 — Camarillo, California, United States
- Sharp Chula Vista Medical Center — Chula Vista, California, United States
- Local Institution - 039 — Garden Grove, California, United States
- Ucsd Medical Center — La Jolla, California, United States
- San Diego Clinical Trials — La Mesa, California, United States
- Local Institution - 010 — Lancaster, California, United States
- Local Institution - 061 — Los Angeles, California, United States
- Southern California Research Institute Medical Group, Inc. — Los Angeles, California, United States
- Matrix Clinical Research Inc — Los Angeles, California, United States
- Local Institution - 110 — Los Angeles, California, United States
- Facey Medical Foundation (Parent) — Mission Hills, California, United States
- ABS Health, LLC — Mission Viejo, California, United States
- Alliance Clinical Research — Oceanside, California, United States
- Local Institution - 027 — Orange, California, United States
- Palo Alto Center-Palo Alto Medical Foundation Research Institute — Palo Alto, California, United States
- Havana Research Institute LLC — Pasadena, California, United States
- Local Institution - 006 — Rialto, California, United States
- Sutter Medical Group — Roseville, California, United States
- Local Institution - 280 — Sacramento, California, United States
- Local Institution - 003 — San Diego, California, United States
- Local Institution - 281 — San Francisco, California, United States
- New Hope Research Development — West Covina, California, United States
- Holland Center for Family Health — Peoria, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.